Arrow International and Johns Hopkins Awarded Judgment Against Datascope in Patent Litigation
26 June 2007 - 8:40AM
PR Newswire (US)
READING, Pa., June 25 /PRNewswire-FirstCall/ -- A judgment was
awarded to The Johns Hopkins University and Arrow International,
Inc. in their patent infringement lawsuit against Datascope Corp.
on Friday, June 15, 2007, in the United States District Court in
Baltimore, Maryland. Johns Hopkins and Arrow had brought suit
against Datascope for infringing patents relating to the
Arrow-Trerotola(TM) Percutaneous Thrombolytic Device (PTD(R)), a
device used by interventionalists for treating hemodialysis
patients. The Baltimore jury found that the Datascope ProLumen
device infringed three patents owned by Johns Hopkins and licensed
by Arrow, and upheld their validity. The jury also awarded damages
amounting to an 18% royalty on Datascope's sales of the infringing
device. Johns Hopkins and Arrow have asked the court to issue a
permanent injunction against Datascope's sales of the ProLumen. Dr.
Scott O. Trerotola, now with the University of Pennsylvania,
invented the PTD as a device to clean clotted dialysis grafts in
the early 1990's while working at Johns Hopkins. Arrow has an
exclusive license for the technology, and has recently celebrated
the ten year anniversary of the Arrow-Trerotola PTD. During this
decade, tens of thousands of patients have been treated with the
Arrow-Trerotola device. Arrow's CEO Phil Fleck said, "We are
pleased that the Court affirmed the Johns Hopkins and Arrow patent
rights and expect continuing success with the Arrow-Trerotola PTD."
Johns Hopkins and Arrow were represented by Kenneth George, Ira
Silfin, Marc Jason, and Rebecca Eisenberg of Amster, Rothstein
& Ebenstein LLP, an intellectual property law firm in New York.
About Arrow Arrow International, Inc., develops, manufactures and
markets a broad selection of clinically advanced, disposable
catheters and related products for critical and cardiac care. The
company's products are used primarily by anesthesiologists,
critical care specialists, interventional radiologists, surgeons,
emergency and trauma physicians, cardiologists, and other
healthcare providers. The company's common stock trades on NASDAQ
Global Select Market(SM) under the symbol ARRO. For more
information, visit http://www.arrowintl.com/. DATASOURCE: Arrow
International, Inc. CONTACT: Investors, Frederick J. Hirt, Chief
Financial Officer of Arrow International, Inc., +1-610-478-3117 Web
site: http://www.arrowintl.com/
Copyright